Cargando…
Safety of Intranasal Ketamine for Reducing Uncontrolled Cancer-Related Pain: Protocol of a Phase I/II Clinical Trial
BACKGROUND: Approximately 12 million Americans are affected with cancer. Of these, 53% experience pain at all stages of cancer. Pain may remain uncontrolled despite high-dose opioid therapy, and opioids have many well-documented harmful side effects. Intranasal ketamine has been shown to be effectiv...
Autores principales: | Shteamer, Jack W, Harvey, R Donald, Spektor, Boris, Curseen, Kimberly, Egan, Katherine, Chen, Zhengjia, Gillespie, Theresa W, Sniecinski, Roman M, Singh, Vinita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658277/ https://www.ncbi.nlm.nih.gov/pubmed/31038469 http://dx.doi.org/10.2196/12125 |
Ejemplares similares
-
3447 Effects of intranasal ketamine on uncontrolled cancer related pain
por: Singh, Vinita, et al.
Publicado: (2019) -
A comparison of intranasal ketamine and intranasal midazolam for pediatric premedication
por: Narendra, P. L., et al.
Publicado: (2015) -
Comparative Study of Intranasal Dexmedetomidine Versus Intranasal Ketamine as Premedicant in Children
por: Arun, Nidhi, et al.
Publicado: (2022) -
The Safety, Clinical, and Neurophysiological Effects of Intranasal Ketamine in Patients Who Do Not Respond to Electroconvulsive Therapy: Protocol for a Pilot, Open-Label Clinical Trial
por: Knyahnytska, Yuliya, et al.
Publicado: (2022) -
Intranasal sedation using ketamine and midazolam for pediatric dental treatment (NASO): study protocol for a randomized controlled trial
por: Gomes, Heloisa Sousa, et al.
Publicado: (2017)